Cargando…
High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer
The investigation of specific genes will establish more useful biomarkers for accurate detection and management of gynecological cancers, especially patients with cervical cancer (CCP). The aim of this study was to evaluate the expression level of RIPK4 and EZH2 messenger RNA (RIPK4 and EZH2 mRNA) i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841057/ https://www.ncbi.nlm.nih.gov/pubmed/27697098 http://dx.doi.org/10.3727/096504016X14749735594687 |
_version_ | 1783643717138120704 |
---|---|
author | Azizmohammadi, Susan Azizmohammadi, Sima Safari, Aghdas Kaghazian, Maria Sadrkhanlo, Mina Behnod, Vahid Seifoleslami, Mehri |
author_facet | Azizmohammadi, Susan Azizmohammadi, Sima Safari, Aghdas Kaghazian, Maria Sadrkhanlo, Mina Behnod, Vahid Seifoleslami, Mehri |
author_sort | Azizmohammadi, Susan |
collection | PubMed |
description | The investigation of specific genes will establish more useful biomarkers for accurate detection and management of gynecological cancers, especially patients with cervical cancer (CCP). The aim of this study was to evaluate the expression level of RIPK4 and EZH2 messenger RNA (RIPK4 and EZH2 mRNA) in CCP. Expression of RIPK4 and EZH2 in the tissues was determined by immunohistochemistry and qRT-PCR methods. Correlations of RIPK4 and EZH2 mRNA with clinical and pathological parameters were analyzed using the Fisher’s exact test. The mRNA level of RIPK4 was significantly upregulated in tumor tissues compared with matched adjacent normal tissues (4.10 ± 0.89 vs. 1.5 ± 0.82; p = 0.021). EZH2 mRNA was increased in cancer tissues compared to normal tissues (3.54 ± 0.71 vs. 1.2 ± 0.65; p = 0.003). High expression of RIPK4 was observed in 25 patients (64.1%), whereas weak expression was seen in 14 cases (35.9%). Furthermore, the expression of RIPK4 was overexpressed in matched adjacent normal tissues (p = 0.004). FIGO stage and lymph node metastasis were significantly linked to a higher expression of RIPK4 (p < 0.05). Overexpression of EZH2 was found in 30 patients (76.9%) and was associated with FIGO stage, histological type, and lymph node metastasis (p < 0.05). In conclusion, our data suggest that RIPK4/EZH2 markers might be used as potential predictors of prognosis in cervical cancer. |
format | Online Article Text |
id | pubmed-7841057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cognizant Communication Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-78410572021-02-16 High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer Azizmohammadi, Susan Azizmohammadi, Sima Safari, Aghdas Kaghazian, Maria Sadrkhanlo, Mina Behnod, Vahid Seifoleslami, Mehri Oncol Res Article The investigation of specific genes will establish more useful biomarkers for accurate detection and management of gynecological cancers, especially patients with cervical cancer (CCP). The aim of this study was to evaluate the expression level of RIPK4 and EZH2 messenger RNA (RIPK4 and EZH2 mRNA) in CCP. Expression of RIPK4 and EZH2 in the tissues was determined by immunohistochemistry and qRT-PCR methods. Correlations of RIPK4 and EZH2 mRNA with clinical and pathological parameters were analyzed using the Fisher’s exact test. The mRNA level of RIPK4 was significantly upregulated in tumor tissues compared with matched adjacent normal tissues (4.10 ± 0.89 vs. 1.5 ± 0.82; p = 0.021). EZH2 mRNA was increased in cancer tissues compared to normal tissues (3.54 ± 0.71 vs. 1.2 ± 0.65; p = 0.003). High expression of RIPK4 was observed in 25 patients (64.1%), whereas weak expression was seen in 14 cases (35.9%). Furthermore, the expression of RIPK4 was overexpressed in matched adjacent normal tissues (p = 0.004). FIGO stage and lymph node metastasis were significantly linked to a higher expression of RIPK4 (p < 0.05). Overexpression of EZH2 was found in 30 patients (76.9%) and was associated with FIGO stage, histological type, and lymph node metastasis (p < 0.05). In conclusion, our data suggest that RIPK4/EZH2 markers might be used as potential predictors of prognosis in cervical cancer. Cognizant Communication Corporation 2017-04-14 /pmc/articles/PMC7841057/ /pubmed/27697098 http://dx.doi.org/10.3727/096504016X14749735594687 Text en Copyright © 2017 Cognizant, LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License. |
spellingShingle | Article Azizmohammadi, Susan Azizmohammadi, Sima Safari, Aghdas Kaghazian, Maria Sadrkhanlo, Mina Behnod, Vahid Seifoleslami, Mehri High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer |
title | High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer |
title_full | High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer |
title_fullStr | High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer |
title_full_unstemmed | High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer |
title_short | High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer |
title_sort | high-level expression of ripk4 and ezh2 contributes to lymph node metastasis and predicts favorable prognosis in patients with cervical cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841057/ https://www.ncbi.nlm.nih.gov/pubmed/27697098 http://dx.doi.org/10.3727/096504016X14749735594687 |
work_keys_str_mv | AT azizmohammadisusan highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer AT azizmohammadisima highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer AT safariaghdas highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer AT kaghazianmaria highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer AT sadrkhanlomina highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer AT behnodvahid highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer AT seifoleslamimehri highlevelexpressionofripk4andezh2contributestolymphnodemetastasisandpredictsfavorableprognosisinpatientswithcervicalcancer |